Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Supernus Pharmaceuticals Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Supernus Pharmaceuticals Inc. June 18, 202688.4%
-
Supernus Pharmaceuticals Inc. June 16, 202375.3%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 2, 2026 | Supernus Pharmaceuticals Inc. | Other | −124,119 | — | — |
| Feb 24, 2026 | Supernus Pharmaceuticals Inc. | Grant or award | +4,475 | — | — |
| Nov 21, 2025 | Supernus Pharmaceuticals Inc. | Option exercise | +15,000 | $12.98 | $194,700 |
| Oct 9, 2025 | Supernus Pharmaceuticals Inc. | Open-market sale | −23,800 | $50.73 | $1,207,374 |
| Oct 9, 2025 | Supernus Pharmaceuticals Inc. | Open-market sale | −1,200 | $51.55 | $61,860 |
| Aug 27, 2025 | Supernus Pharmaceuticals Inc. | Open-market sale | −3,588 | $45.01 | $161,496 |
| Aug 25, 2025 | Supernus Pharmaceuticals Inc. | Open-market sale | −1,000 | $45.00 | $45,000 |
| Aug 22, 2025 | Supernus Pharmaceuticals Inc. | Open-market sale | −1,412 | $45.00 | $63,540 |
| Feb 22, 2025 | Supernus Pharmaceuticals Inc. | Grant or award | +5,369 | — | — |
| Nov 11, 2024 | Supernus Pharmaceuticals Inc. | Option exercise | +20,000 | $9.13 | $182,600 |
| Nov 11, 2024 | Supernus Pharmaceuticals Inc. | Open-market sale | −10,700 | $36.24 | $387,768 |
| Feb 23, 2024 | Supernus Pharmaceuticals Inc. | Grant or award | +3,886 | — | — |
| Nov 16, 2023 | Supernus Pharmaceuticals Inc. | Option exercise | +7,457 | $9.24 | $68,903 |
| Nov 16, 2023 | Supernus Pharmaceuticals Inc. | Open-market sale | −2,500 | $28.01 | $70,025 |
| Feb 22, 2023 | Supernus Pharmaceuticals Inc. | Grant or award | +3,882 | — | — |
Questions about Charles W. Newhall III
What boards is Charles W. Newhall III on?
Charles W. Newhall III sits on the board of Supernus Pharmaceuticals Inc.
How long has Charles W. Newhall III served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.